Europe — EMA

Paliperidona Teva (Paliperidone)

Paliperidone, the active ingredient in Paliperidona Teva, is a atypical antipsychotic presented as a tablet for oral use. It is indicated for the treatment of schizophrenia and schizoaffective disorder in adults.

Paliperidone

Request sourcing

Pack/s

What is Paliperidone?

GNH USA supplies Paliperidona Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Paliperidone used for?

Paliperidone is used in the management of psychotic disorders, acting on dopamine pathways to control symptoms. - Schizophrenia: Reduces positive and negative symptoms and helps prevent relapse. - Schizoaffective disorder: Improves mood and psychotic symptom control. - Bipolar I disorder (adjunctive): May stabilize mood when used with other therapies.

What are the side effects of Paliperidone?

Paliperidone may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Akathisia : Restlessness of the ... - ... ... ... ... ... ...

Serious or Rare Side Effects: - ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...

What precautions apply to Paliperidone?

The ... ... ... ... ... ... .... .... .... .... ... .... ... ... .... ... ... ... ... ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →